Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old

NCT01992107 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2333

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: QIVc
BIOLOGICAL: TIV1c
BIOLOGICAL: TIV2c

Sponsor

Novartis Vaccines